ACK1: Small molecule ACK1 Inhibitors for the Treatment of Castrate Resistant Prostate Cancer

FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE

Contact

Haskell Adler PhD MBA CLP
Senior Licensing Manager
Haskell.Adler@Moffitt.org
(813) 745-6596